Key result
Percutaneous closure of a large post-infarct basal ventricular septal defect was successfully achieved using a 28 mm atrial septal defect closure device without residual shunt or procedural complications.
Why the study?
Ventricular septal defect is a rare, life-threatening complication of MI requiring immediate diagnosis and treatment, with transcatheter closure serving as a new alternative to surgery.
Case Report (n=1)
No
Percutaneous closure of a large post-infarct basal ventricular septal defect using an ASD closure device is a feasible alternative to surgery in high-risk patients.
May support transcatheter post-MI VSD closure with ASD occluder; hypothesis-generating for dedicated devices and trials.
Ventricular Septal Defect, also known as VSD is a rare and life-threatening complication associated with MI. Therefore, it should be immediately diagnosed and treated. Transcatheter closure of the ventricular septal defect is a new alternative treatment approach compared to surgery. In this case, we presented a patient with post-infarct basal ventricular septal defect whose ventricular septal defect was closed using an atrial septal defect closure device. The ability to successfully close such a large defect via catheter is promising for the treatment of patients with VSD.
No takes yet. Share an insight, caveat, or question.
Ceyhun et al. (2024) conducted a case report in Post-infarct basal ventricular septal defect (n=1). Percutaneous closure using an Atrial Septal Defect (ASD) closure device was evaluated on Successful closure of VSD without residual shunt. Percutaneous closure of a large post-infarct basal ventricular septal defect was successfully achieved using a 28 mm atrial septal defect closure device without residual shunt or procedural complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: